The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option.

The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option.

Item
http://www.wikidata.org/entity/Q36462675
Rituximab in the Treatment of Thyroid Eye Disease: A ReviewRituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathyImmunopathogenesis of thyroid eye disease: emerging paradigmsDecrease in proportion of CD19+ CD24(hi) CD27+ B cells and impairment of their suppressive function in Graves' disease.Hyperthyroidism in childhood: causes, when and how to treat.B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family.B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis.Manipulating B cell homeostasis: a key component in the advancement of targeted strategiesImmune mechanisms in thyroid eye disease.Pathogenesis of Graves' orbitopathy: a 2010 update.Current trends in antithyroid drug treatment of Graves' disease.Rapid response to and long-term effectiveness of anti-CD20 antibody in conventional therapy resistant Graves' orbitopathy: A five-year follow-up study.Thyroid-specific changes following treatment with biological therapies in patients with rheumatic diseases.Nonthionamide Drugs for the Treatment of Hyperthyroidism: From Present to Future.Reduction of orbital inflammation following decompression for thyroid-related orbitopathy.2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism
P2860

The rationale for B lymphocyte depletion in Graves' disease. Monoclonal anti-CD20 antibody therapy as a novel treatment option.

Item
http://www.wikidata.org/entity/Q36462675
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The rationale for B lymphocyte ...... y as a novel treatment option.
@ast
The rationale for B lymphocyte ...... y as a novel treatment option.
@en
type
label
The rationale for B lymphocyte ...... y as a novel treatment option.
@ast
The rationale for B lymphocyte ...... y as a novel treatment option.
@en
prefLabel
The rationale for B lymphocyte ...... y as a novel treatment option.
@ast
The rationale for B lymphocyte ...... y as a novel treatment option.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
The rationale for B lymphocyte ...... py as a novel treatment option
@en
P2093
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921